InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

Vivos Therapeutics, Inc.

VVOS Clue Score24
United States Fiscal year ends December CIK 0001716166
$0.15 -0.40% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.15 −95.92% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 11 Dec 2020. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2019Revenue11.4Operating income−10.6Net income−10.8Fiscal year 2020Revenue13.1 +14.7%Operating income−12.0Net income−12.1Fiscal year 2021Revenue16.9 +29.2%Operating income−20.4Net income−20.3Fiscal year 2022Revenue16.0 −5.1%Operating income−25.0Net income−23.8EPS, diluted−25.90Fiscal year 2023Revenue13.8 −13.9%Operating income−17.3Net income−13.6EPS, diluted−11.14Fiscal year 2024Revenue15.0 +8.9%Operating income−11.2Net income−11.1EPS, diluted−2.22Fiscal year 2025Revenue17.4 +16.0%Operating income−19.9Net income−21.2EPS, diluted−2.07
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 11.4 13.1 16.9 16.0 13.8 15.0 17.4
Growth +14.7% +29.2% −5.1% −13.9% +8.9% +16.0%
Operating income −10.6 −12.0 −20.4 −25.0 −17.3 −11.2 −19.9
Net income −10.8 −12.1 −20.3 −23.8 −13.6 −11.1 −21.2
Growth
EPS, diluted n/a n/a n/a −25.90 −11.14 −2.22 −2.07

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2019Gross margin76.0%Operating margin−92.8%Net margin−94.4%Free cash flow margin−48.4%Fiscal year 2020Gross margin79.7%Operating margin−92.1%Net margin−92.3%Free cash flow margin−44.4%Fiscal year 2021Gross margin74.6%Operating margin−120.7%Net margin−120.2%Free cash flow margin−107.4%Fiscal year 2022Gross margin62.5%Operating margin−156.2%Net margin−148.8%Free cash flow margin−128.0%Fiscal year 2023Gross margin59.9%Operating margin−125.3%Net margin−98.4%Free cash flow margin−92.4%Fiscal year 2024Gross margin60.0%Operating margin−74.3%Net margin−74.1%Free cash flow margin−88.2%Fiscal year 2025Gross margin60.4%Operating margin−114.1%Net margin−121.4%Free cash flow margin−100.9%
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 76.0% 79.7% 74.6% 62.5% 59.9% 60.0% 60.4%
Operating margin −92.8% −92.1% −120.7% −156.2% −125.3% −74.3% −114.1%
Net margin −94.4% −92.3% −120.2% −148.8% −98.4% −74.1% −121.4%
Free cash flow margin −48.4% −44.4% −107.4% −128.0% −92.4% −88.2% −100.9%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2019Operating cash flow−5.3Capital expenditure−0.2Free cash flow−5.5Fiscal year 2020Operating cash flow−5.7Capital expenditure−0.1Free cash flow−5.8Fiscal year 2021Operating cash flow−15.7Capital expenditure−2.4Free cash flow−18.1Fiscal year 2022Operating cash flow−19.6Capital expenditure−0.9Free cash flow−20.5Fiscal year 2023Operating cash flow−11.9Capital expenditure−0.8Free cash flow−12.7Fiscal year 2024Operating cash flow−12.7Capital expenditure−0.6Free cash flow−13.3Fiscal year 2025Operating cash flow−15.3Capital expenditure−2.3Free cash flow−17.6
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −5.3 −5.7 −15.7 −19.6 −11.9 −12.7 −15.3
Capital expenditure −0.2 −0.1 −2.4 −0.9 −0.8 −0.6 −2.3
Free cash flow −5.5 −5.8 −18.1 −20.5 −12.7 −13.3 −17.6
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2019Cash0.5Total debt7.4Net cash (debt)−6.9Shareholders’ equity−2.9Fiscal year 2020Cash18.2Total debt1.3Net cash (debt)16.9Shareholders’ equity16.9Debt to equity0.08Fiscal year 2021Cash24.0Total debt2.5Net cash (debt)21.5Shareholders’ equity25.5Debt to equity0.10Fiscal year 2022Cash3.5Shareholders’ equity4.8Fiscal year 2023Cash1.6Shareholders’ equity0.4Fiscal year 2024Cash6.3Shareholders’ equity8.0Fiscal year 2025Cash2.0Total debt8.8Net cash (debt)−6.8Shareholders’ equity−1.5
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 0.5 18.2 24.0 3.5 1.6 6.3 2.0
Total debt 7.4 1.3 2.5 n/a n/a n/a 8.8
Net cash (debt) −6.9 16.9 21.5 n/a n/a n/a −6.8
Shareholders’ equity −2.9 16.9 25.5 4.8 0.4 8.0 −1.5
Debt to equity n/a 0.08 0.10 n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024† 31 Dec 2024 FY2025† 31 Dec 2025
Operations
−5.3 −5.7 −15.7 −19.6 −11.9 −12.7 −15.3
Growth
n/a n/a 0.7 0.7 0.6 0.6 1.3
Investment
−0.2 −0.1 −2.4 −0.9 −0.8 −0.6 −2.3
calc −5.5 −5.8 −18.1 −20.5 −12.7 −13.3 −17.6
Growth
calc n/a n/a n/a −22.28 −10.46 −2.64 −1.71
0.1 −0.1 −2.6 −0.9 −0.9 −0.6 −7.5
Financing
4.5 23.5 24.2 n/a 10.9 17.9 18.6

† The diluted share count jumps at 2024 and 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.